Home
About Us
Company Overview
Innovation and Leadership
Products
Discovery
Company Highlights
Company History
Our People
Senior Management
Our Reach
Awards and Recognition
Australian Industry Participation Purchasing Policy
Positions Vacant
Legal Disclaimer
Our Products
Aridol
Aridol Patient Profiles
Current clinical trials
Bronchitol
Bronchitol Patient Profiles
Current clinical trials
Respiratory Diseases
Compassionate Use Programs
Scientific Publications
Patents
Investors
ASX Announcements
ASX 2010
ASX 2009
ASX 2008
ASX 2007
ASX 2006
ASX 2005
ASX 2004
ASX 2003
News
Quarterly Reports
Annual Reports & Reviews
Investor Presentations
2010
2009
2008
2007
2006
2005
2004
2003
Share Price
Shareholder Services
Join Our Mailing List
Contact Us
Events Calendar
Financial Summary
Analyst Coverage
Shareholders
Corporate Directory
Corporate Governance
Business Overview
SEC Filings
News
Media Releases
Media 2010
Media 2009
Media 2008
Media 2007
Media 2006
Media 2005
Media 2004
Media 2003
Quarterly Reports
Quarterly Reports 2010
Quarterly Reports 2009
Quarterly Reports 2008
Quarterly Reports 2007
Quarterly Reports 2006
Quarterly Reports 2005
Quarterly Reports 2004
Media Contact
News Feeds
New Product Pipeline
Clinical Trials
Scientific Publications
Investigator-Initiated Studies
Clinical Development Pipeline
Respiratory diseases
Patents
Contact Us
Health Professionals
Distributors
Patients
Media Releases
Quarterly Reports
Media Contact
News Feeds
Pharmaxis
Home
News
Media Releases
Media 2006
Media Releases
MEDIA RELEASES
14.12.2006 - Dutch Distributor of Aridol Appointed (29KB)
22.11.2006 - Bronchitol Receives Fast Track Status (26KB)
16.11.2006 - US Aridol Phase III results (33KB)
16.11.2006 - Aridol Endorsed in Global Guidelines (41KB)
15.11.2006 - John Villiger Appointed to Board (21KB)
26.10.2006 - Chairman's Address to Shareholders (25KB)
25.10.2006 - Swedish Approval for Aridol (30KB)
19.10.2006 - Aridol Distributor for Italy Appointed (28KB)
06.10.2006 - Pharmaxis Receives UK Approval for Phase 3 Cystic Fibrosis Trial (40KB)
03.10.2006 - Pharmaxis Appoints Aridol Distributor for Greece (29KB)
22.09.2006 - Board Change (23KB)
28.08.2006 - US Aridol Trial Closes (30KB)
09.08.2006 - Quarterly Conference Call, 9 August 2006 (21KB)
04.08.2006 - Pharmaxis Investor Conference Call (30KB)
20.07.2006 - Aridol Marketing Application Filed in Switzerland (27KB)
30.06.2006 - Pharmaxis' First Commercial Supply of Aridol to U.S. Market (29KB)
02.05.2006 - Pharmaxis Reports FDA and EMEA End of Phase II meetings (28KB)
19.04.2006 - Pharmaxis Enrols First Patient in Phase III Bronchiectasis Trial (111KB)
11.04.2006 - Pharmaxis Board Change (25KB)
11.04.2006 - Pharmaxis Completes Enrolment in Aridol COPD Trial (63KB)
07.04.2006 - TGA Licence to Manufacture Re-issued and Upgraded (43KB)
23.03.2006 - Aridol Approved by the TGA (40KB)
20.03.2006 - Majority of Pharmaxis Board Now Independent (98KB)
16.03.2006 - Peter Farrell Joins Pharmaxis Board (89KB)
03.03.2006 - PXS Admitted to S&P/ASX 300 (175KB)
13.02.2006 - Aridol Recommended for market authorisation by ADEC (92KB)
06.02.2006 - Pharmaxis Signs Swiss Marketing Partner for Aridol (103KB)
06.02.2006 - Pharmaxis Commences Operations in Europe (102KB)
18.01.2006 - Pharmaxis Signs First Distributor For Aridol (103KB)
PAGE CONTENTS
Media 2010
Media 2009
Media 2008
Media 2007
Media 2006
Media 2005
Media 2004
Media 2003